Two Sigma Investments
SBBP

Two Sigma Investments’s Strongbridge Biopharma plc. SBBP Stock Holding History

Two Sigma Investments’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,300
Closed -$48K – 4923
2021
Q2 		$48K Sell
16,300
-43,100
-73% -$114K ﹤0.01% 3947
2021
Q1 		$164K Sell
59,400
-273,741
-82% -$826K ﹤0.01% 3660
2020
Q4 		$810K Sell
333,141
-108,311
-25% -$261K ﹤0.01% 2159
2020
Q3 		$927K Buy
441,452
+373,370
+548% +$1.26M ﹤0.01% 1814
2020
Q2 		$257K Sell
68,082
-9,965
-13% -$29.9K ﹤0.01% 2480
2020
Q1 		$148K Buy
+78,047
New +$203K ﹤0.01% 2751
2019
Q1 		– Sell
-40,590
Closed -$182K – 3602
2018
Q4 		$182K Sell
40,590
-176,791
-81% -$863K ﹤0.01% 2730
2018
Q3 		$1.05M Buy
217,381
+109,506
+102% +$560K ﹤0.01% 1937
2018
Q2 		$647K Buy
107,875
+93,175
+634% +$682K ﹤0.01% 2462
2018
Q1 		$130K Buy
+14,700
New +$110K ﹤0.01% 3023

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Two Sigma Investments's SBBP Position: Q3 2021 in Review

Two Sigma Investments sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 16,300 shares — an estimated $48K sold.

Two Sigma Investments first reported a position in SBBP in Q1 2018 and held it in 10 quarters. The position peaked at $1.05M in Q3 2018. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Two Sigma Investments reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Investments sold 16,300 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $48K.
  • Two Sigma Investments first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 10 quarters.
  • Two Sigma Investments's Strongbridge Biopharma plc. position peaked at $1.05M in Q3 2018.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.